XFOR Total Utang marang Modal X4 Pharmaceuticals, Inc
The X4 Pharmaceuticals (XFOR) price chart demonstrates a total debt-to-equity ratio of 0.47. Business revenues are based on the market launch of mavorixafor, an innovative treatment for WHIM syndrome. The company is currently focusing on independent promotion within US medical centers and distribution partnerships. Leading immunology experts, attracted by large-scale investments in scientific research, are driving this success.
Rincian analitis lan laporan data perusahaan X4 Pharmaceuticals, Inc (XFOR)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Utang marang Ekuitas X4 Pharmaceuticals|XFOR - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal X4 Pharmaceuticals|XFOR - Gunggung utang perusahaan|Utang marang nilai buku X4 Pharmaceuticals|XFOR - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan X4 Pharmaceuticals
Analisis komprehensif perusahaan:XFOR - X4 Pharmaceuticals, Inc.
This indicator measures the degree of financial leverage by comparing total credit obligations against net assets to assess the stability of the financing structure. Analyzing the total debt-to-equity ratio determines how effectively X4 Pharmaceuticals (XFOR) utilizes borrowed funds to scale its immunological ecosystem and ensure long-term care for a patient base with rare blood pathologies.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|SEPN - Utang marang Modal|Pieris Pharmaceuticals Inc (PVLA) - Rasio Total Utang marang Ekuitas|SVRA (Savara Pharma) - Rasio Utang marang Ekuitas|RIGL (Rigel Pharmaceuticals) - Rasio Utang marang Ekuitas|anaptysbio.com - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Astria Therapeutics, Inc.|enGene Holdings Inc - Utang marang Ekuitas|Utang Agregat marang Ekuitas RAPT|JBIO (aerovatetx.com) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ACRS (Aclaris Therapeutics)|Total Utang marang Modal kyvernatx.com KYTX|TLSA - Total Utang marang Modal|Utang marang Ekuitas CABA (Cabaletta Bio Inc.)|Ventyx Bio (VTYX) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Theratechnologies, Inc|AVTX (Avalo Therapeutics, Inc) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal eledon.com|Total Utang marang Modal AGEN|Total Utang marang Modal Climb Bio Inc. CLYM|Rasio Total Utang marang Ekuitas ZURA (Zura Bio Limited)|aTyr Pharmaceuticals (ATYR) - Total Utang marang Modal|ADAG: Utang marang Modal|IMA - Rasio Total Utang marang Ekuitas|STTK (shattucklabs.com) - Total Utang marang Modal|EQ: Rasio Total Utang marang Ekuitas|CNTB (Connect Biopharma Holdings) - Utang Agregat marang Modal|Immunic Inc (IMUX) - Total Utang marang Modal|Koefisien Total Utang marang Modal ATRA|Total Utang marang Modal inflarx.de IFRX|Rasio Total Utang marang Ekuitas ACET (Adicet Bio, Inc.)|Total Utang marang Modal Celularity Inc CELU|INMB - Total Utang marang Modal|BRNS: Utang marang Ekuitas|Kezar Life Sciences (KZR) - Utang marang Ekuitas|SABS - Utang marang Ekuitas|Koefisien Total Utang marang Modal AKTX|Rasio Total Utang marang Ekuitas ENLV (Enlivex Therapeutics, Ltd.)|Rasio Utang marang Ekuitas QTTB|GOVX: Total Utang marang Modal|Utang Agregat marang Ekuitas Edesa Biotech, Inc. EDSA|ibioinc.com (IBIO) - Utang marang Ekuitas|CARM - Utang marang Modal|Utang marang Ekuitas XTLB (XTL Biopharmaceuticals Ltd)|boltbio.com (BOLT) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas HCWB (HCW Biologics)|APVO (Aptevo Therapeutics, Inc.) - Utang Agregat marang Ekuitas|AIM: Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADTX|Total Utang marang Modal GRI Bio Inc (GRI)|Total Utang marang Modal XORTX XRTX|Utang marang Ekuitas HIND|REVB - Rasio Kabeh Utang marang Dana Pribadi|indaptusrx.com (INDP) - Utang marang Ekuitas|SCNI: Rasio Total Utang marang Ekuitas|CalciMedica (CALI) - Total Utang marang Modal|Total Utang marang Modal AFMD|ALLK: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi HOOK|Total Utang marang Modal igmbio.com|Koefisien Total Utang marang Modal iTeos Therapeutics, Inc. ITOS|OCEA - Utang marang Ekuitas|TCBP - Rasio Total Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Utang marang Ekuitas